Gating defects of disease-causing de novo mutations in Ca_v1.3 Ca²⁺ channels

References

• Striessnig J, Pinggera A, Kaur G, et al. L-type calcium channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal. 2014;3:15–38.
   PubMedGoogle Scholar
• Zamponi GW, Striessnig J, Koschak A, et al. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67:821–870.
   PubMed Web of Science ®Google Scholar
• Nanou E, Catterall WA. Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease. Neuron. 2018;98:466–481.
   PubMed Web of Science ®Google Scholar
• Tottene A, Pivotto F, Fellin T, et al. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem. 2005;280:17678–17686.
   PubMed Web of Science ®Google Scholar
• van Den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41:701–710.
   PubMed Web of Science ®Google Scholar
• Kraus RL, Sinnegger MJ, Glossmann H, et al. Familial hemiplegic migraine mutations change alpha1A calcium channel kinetics. J Biol Chem. 1998;273:5586–5590.
   PubMed Web of Science ®Google Scholar
• Kraus RL, Sinnegger MJ, Koschak A, et al. Three New Familial Hemiplegic Migraine Mutants Affect P/Q-type Calcium Channel Kinetics. J Biol Chem. 2000;275:9239–9243.
   PubMed Web of Science ®Google Scholar
• Adams PJ, Garcia E, David LS, et al. Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels (Austin). 2009;3:110–121.
   PubMed Web of Science ®Google Scholar
• Pinggera A, Mackenroth L, Rump A, et al. New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy. Hum Mol Genet. 2017;26:2923–2932.
   PubMed Web of Science ®Google Scholar
• Pinggera A, Lieb A, Benedetti B, et al. CACNA1D De Novo Mutations in Autism Spectrum Disorders Activate Cav1.3 L-Type Calcium Channels. Biol Psychiatry. 2015;77:816–822.
   PubMed Web of Science ®Google Scholar
• Azizan EAB, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055–1060.
   PubMed Web of Science ®Google Scholar
• Tan GC, Negro G, Pinggera A, et al. Aldosterone-Producing Adenomas: histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation. Hypertension. 2017;70:129–136.
   PubMed Web of Science ®Google Scholar
• Flanagan SE, Vairo F, Johnson MB, et al. A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia. Pediatr Diabetes. 2017;18:320–323.
   PubMed Web of Science ®Google Scholar
• Garza-Lopez E, Lopez JA, Hagen J, et al. Role of a conserved glutamine in the function of voltage-gated Ca(2+) channels revealed by a mutation in human CACNA1D. J Biol Chem. 2018;293:14444–14454.
   PubMed Web of Science ®Google Scholar
• Scholl UI, Goh G, Stolting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050–1054.
   PubMed Web of Science ®Google Scholar
• Limpitikul WB, Dick IE, Ben-Johny M, et al. An autism-associated mutation in Cav1.3 channels has opposing effects on voltage- and Ca2+-dependent regulation. Sci. Rep. 2016;6:27235.
   PubMed Web of Science ®Google Scholar
• Barrett PQ, Guagliardo NA, Klein PM, et al. Role of voltage-gated calcium channels in the regulation of aldosterone production from zona glomerulosa cells of the adrenal cortex. J Physiol. 2016;594:5851–5860.
   PubMed Web of Science ®Google Scholar
• Pinggera A, Striessnig J. Cav1.3 (CACNA1D) L-type Ca2+ channel dysfunction in CNS disorders. J Physiol. 2016;594:5839–5849.
   PubMed Web of Science ®Google Scholar
• Platzer J, Engel J, Schrott-Fischer A, et al. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type calcium channels. Cell. 2000;102:89–97.
   PubMed Web of Science ®Google Scholar
• Baig SM, Koschak A, Lieb A, et al. Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci. 2011;14:77–84.
   PubMed Web of Science ®Google Scholar
• Monteleone S, Lieb A, Pinggera A, et al. Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. Biophys J. 2017;113:1485–1495.
   PubMed Web of Science ®Google Scholar
• Omata K, Anand SK, Hovelson DH, et al. Aldosterone-Producing Cell Clusters Frequently Harbor Somatic Mutations and Accumulate With Age in Normal Adrenals. J Endocr Soc. 2017;1:787–799.
   PubMed Web of Science ®Google Scholar
• Nishimoto K, Tomlins SA, Kuick R, et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S A. 2015;112:E4591–E4599.
   PubMed Web of Science ®Google Scholar
• Monticone S, Buffolo F, Tetti M, et al. GENETICS IN ENDOCRINOLOGY: the expanding genetic horizon of primary aldosteronism. Eur J Endocrinol. 2018;178:R101–R11.
   PubMed Web of Science ®Google Scholar
• Bock G, Gebhart M, Scharinger A, et al. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem. 2011;286:42736–42748.
   PubMed Web of Science ®Google Scholar
• Ortner NJ, Bock G, Dougalis A, et al. Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: implications for Neuroprotection in Parkinson’s Disease. J Neurosci. 2017;37:6761–6777.
   PubMed Web of Science ®Google Scholar
• Lieb A, Ortner N, Striessnig J. C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type calcium channels. Biophys J. 2014;106:1467–1475.
   PubMed Web of Science ®Google Scholar
• Tan BZ, Jiang F, Tan MY, et al. Functional characterization of alternative splicing in the C terminus of L-type Cav1.3 channels. J Biol Chem. 2011;286:42725–42735.
   PubMed Web of Science ®Google Scholar
• Lieb A, Scharinger A, Sartori SB, et al. Structural determinants of Ca(V)1.3 L-type calcium channel gating. Channels. 2012;6:197–205.
   PubMed Web of Science ®Google Scholar
• Ortner NJ, Striessnig J. L-type calcium channels as drug targets in CNS disorders. Channels (Austin). 2016;10:7–13.
   PubMed Web of Science ®Google Scholar
• Singh A, Gebhart M, Fritsch R, et al. Modulation of voltage- and Ca2+-dependent gating of Cav1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem. 2008;283:20733–20744.
   PubMed Web of Science ®Google Scholar
• Liu X, Yang PS, Yang W, et al. Enzyme-inhibitor-like tuning of Ca2+ channel connectivity with calmodulin. Nature. 2010;463:968–972.
   PubMed Web of Science ®Google Scholar
• Wu J, Yan Z, Li Z, et al. Structure of the voltage-gated calcium channel Cav1.1 at 3.6 Å resolution. Nature. 2016;537:191–196.
   PubMed Web of Science ®Google Scholar
• Long SB, Tao X, Campbell EB, et al. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature. 2007;450:376–382.
   PubMed Web of Science ®Google Scholar
• Dragicevic E, Poetschke C, Duda J, et al. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain. 2014;137:2287–2302.
   PubMed Web of Science ®Google Scholar
• Powell KL, Cain SM, Ng C, et al. A Cav3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy. J Neurosci. 2009;29:371–380.
   PubMed Web of Science ®Google Scholar
• Vecchia D, Tottene A, van Den Maagdenberg AM, et al. Abnormal cortical synaptic transmission in Cav2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans. Front Cell Neurosci. 2015;9:8.
   PubMed Web of Science ®Google Scholar
• Wang B, Li X, Zhang X, et al. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients. Medicine (Baltimore). 2015;94:e708.
   PubMed Web of Science ®Google Scholar
• Jiang D, Gamal El-Din TM, Ing C, et al. Structural basis for gating pore current in periodic paralysis. Nature. 2018;557:590–594.
   PubMed Web of Science ®Google Scholar
• Splawski I, Timothy KW, Decher N, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A. 2005;102:8089–8096, discussion 6–8
   PubMed Web of Science ®Google Scholar
• Splawski I, Timothy KW, Sharpe LM, et al. Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19–31.
   PubMed Web of Science ®Google Scholar
• Striessnig J, Bolz HJ, Koschak A. Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. Pflugers Arch. 2010;460:361–374.
   PubMed Web of Science ®Google Scholar
• Jurkat-Rott K, Groome J, Lehmann-Horn F. Pathophysiological role of omega pore current in channelopathies. Front Pharmacol. 2012;3:112.
   PubMed Web of Science ®Google Scholar
• Cannon SC. Voltage-sensor mutations in channelopathies of skeletal muscle. J Physiol. 2010;588:1887–1895.
   PubMed Web of Science ®Google Scholar